Avadel Pharma (AVDL) Misses Q3 EPS by 3c

Avadel Pharma (NASDAQ: AVDL) reported Q3 EPS of ($0.41), $0.03 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $7.01 million versus the consensus estimate of $5.12 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance